Bodington Ellie, Saeed Shakeel R, Smith Michael C F, Stocks Nigel G, Morse Robert P
Warwick Medical School, University of Warwick, Coventry, UK.
Ear Institute, University College London, London, UK.
Cochlear Implants Int. 2021 Jan;22(1):7-16. doi: 10.1080/14670100.2020.1793070. Epub 2020 Jul 16.
Globally, less than 1% of people who could benefit from a cochlear implant have one and the problem is particularly acute in lower-income countries. Here we give a narrative review of the economic and logistic feasibility of cochlear implant programmes in lower-income countries and discuss future developments that would enable better healthcare. We review the incidence and aetiology of hearing loss in low- and middle-income countries, screening for hearing loss, implantation criteria, issues concerning imaging and surgery, and the professional expertise required. We also review the cost of cochlear implantation and ongoing costs. The cost effectiveness of cochlear implants in lower-income countries is more limited by the cost of the device than the cost of surgery, but there are also large ongoing costs that will deter many potential users. We conclude that the main barriers to the future uptake of cochlear implants are likely to be logistical rather than technical and cochlear implant provision should be considered as part of a wider programme to improve the health of those with hearing loss.
在全球范围内,能够从人工耳蜗植入中受益的人群中,只有不到1%的人接受了植入手术,而这一问题在低收入国家尤为严重。在此,我们对低收入国家人工耳蜗植入项目的经济和后勤可行性进行叙述性综述,并讨论有助于改善医疗保健的未来发展方向。我们回顾了低收入和中等收入国家听力损失的发病率及病因、听力损失筛查、植入标准、影像学及手术相关问题以及所需的专业知识。我们还回顾了人工耳蜗植入的成本及后续费用。在低收入国家,人工耳蜗植入的成本效益更多地受到设备成本而非手术成本的限制,但后续还有大量费用,这将阻碍许多潜在使用者。我们得出结论,未来人工耳蜗植入普及的主要障碍可能是后勤方面而非技术方面,应将人工耳蜗植入视为改善听力损失者健康的更广泛项目的一部分。